AO
Advisor OS’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,006
| Closed | -$302K | – | 453 |
|
|
2025
Q1 | $302K | Sell |
2,006
-879
| -30% | -$132K | 0.03% | 322 |
|
|
2024
Q4 | $533K | Sell |
2,885
-11,250
| -80% | -$2.08M | 0.06% | 216 |
|
|
2024
Q3 | $2.78M | Sell |
14,135
-2,429
| -15% | -$478K | 0.28% | 62 |
|
|
2024
Q2 | $3.42M | Buy |
16,564
+2,207
| +15% | +$456K | 0.37% | 44 |
|
|
2024
Q1 | $3.89M | Sell |
14,357
-2
| -0% | -$542 | 0.45% | 37 |
|
|
2023
Q4 | $3.39M | Sell |
14,359
-179
| -1% | -$42.3K | 0.44% | 36 |
|
|
2023
Q3 | $2.85M | Buy |
14,538
+5,794
| +66% | +$1.14M | 0.43% | 41 |
|
|
2023
Q2 | $1.84M | Buy |
8,744
+4,392
| +101% | +$923K | 0.3% | 64 |
|
|
2023
Q1 | $878K | Buy |
4,352
+186
| +4% | +$37.5K | 0.21% | 118 |
|
|
2022
Q4 | $908K | Buy |
4,166
+931
| +29% | +$203K | 0.24% | 96 |
|
|
2022
Q3 | $637K | Sell |
3,235
-609
| -16% | -$120K | 0.19% | 110 |
|
|
2022
Q2 | $822K | Buy |
3,844
+298
| +8% | +$63.7K | 0.24% | 97 |
|
|
2022
Q1 | $1.01M | Buy |
3,546
+389
| +12% | +$110K | 0.29% | 81 |
|
|
2021
Q4 | $1.19M | Buy |
3,157
+347
| +12% | +$131K | 0.24% | 94 |
|
|
2021
Q3 | $1.16M | Buy |
2,810
+400
| +17% | +$165K | 0.25% | 90 |
|
|
2021
Q2 | $890K | Buy |
2,410
+1,003
| +71% | +$370K | 0.18% | 98 |
|
|
2021
Q1 | $408K | Buy |
1,407
+578
| +70% | +$168K | 0.09% | 132 |
|
|
2020
Q4 | $207K | Buy |
+829
| New | +$207K | 0.06% | 131 |
|